Allogene Therapeutics Stock Price History

ALLO Stock  USD 4.47  0.01  0.22%   
Below is the normalized historical share price chart for Allogene Therapeutics extending back to October 11, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Allogene Therapeutics stands at 4.47, as last reported on the 29th of March, with the highest price reaching 4.58 and the lowest price hitting 4.41 during the day.
IPO Date
11th of October 2018
200 Day MA
3.8677
50 Day MA
4.3578
Beta
0.812
 
Covid
If you're considering investing in Allogene Stock, it is important to understand the factors that can impact its price. Allogene Therapeutics appears to be risky, given 3 months investment horizon. Allogene Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0939, which signifies that the company had a 0.0939% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Allogene Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Allogene Therapeutics' Mean Deviation of 3.66, downside deviation of 4.93, and Risk Adjusted Performance of 0.0859 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Allogene Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 29th of March 2024, Liabilities And Stockholders Equity is likely to grow to about 695.7 M, while Common Stock Total Equity is likely to drop about 121.7 K. . At this time, Allogene Therapeutics' Price To Sales Ratio is very stable compared to the past year. As of the 29th of March 2024, Price Earnings To Growth Ratio is likely to grow to 0.18, while Price Earnings Ratio is likely to drop (1.62). Allogene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0939

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsALLO
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.99
  actual daily
44
56% of assets are more volatile

Expected Return

 0.47
  actual daily
9
91% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average Allogene Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Allogene Therapeutics by adding it to a well-diversified portfolio.
Price Book
1.4723
Enterprise Value Ebitda
(1.33)
Price Sales
7.9 K
Shares Float
110.2 M
Wall Street Target Price
9.69

Allogene Therapeutics Stock Price History Chart

There are several ways to analyze Allogene Stock price data. The simplest method is using a basic Allogene candlestick price chart, which shows Allogene Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 6, 20245.63
Lowest PriceJanuary 5, 20242.92

Allogene Therapeutics March 29, 2024 Stock Price Synopsis

Various analyses of Allogene Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Allogene Stock. It can be used to describe the percentage change in the price of Allogene Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Allogene Stock.
Allogene Therapeutics Price Rate Of Daily Change 1.00 
Allogene Therapeutics Price Daily Balance Of Power 0.06 
Allogene Therapeutics Price Action Indicator(0.02)
Allogene Therapeutics Accumulation Distribution 51,136 

Allogene Therapeutics March 29, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Allogene Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Allogene Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Allogene Stock and then apply it to test your longer-term investment strategies against Allogene.

Allogene Stock Price History Data

The price series of Allogene Therapeutics for the period between Sat, Dec 30, 2023 and Fri, Mar 29, 2024 has a statistical range of 2.71 with a coefficient of variation of 19.29. The prices are distributed with arithmetic mean of 4.1. The median price for the last 90 days is 4.26.
OpenHighLowCloseVolume
03/28/2024 4.41  4.58  4.41  4.47  1,377,673 
03/27/2024 4.28  4.63  4.14  4.46  1,897,214 
03/26/2024 4.35  4.47  4.21  4.21  1,281,475 
03/25/2024 4.25  4.47  4.25  4.29  1,259,937 
03/22/2024 4.39  4.47  4.22  4.26  1,507,678 
03/21/2024 4.47  4.57  4.24  4.38  2,496,203 
03/20/2024 4.37  4.47  4.21  4.43  1,968,240 
03/19/2024 4.15  4.45  4.12  4.39  1,966,327 
03/18/2024 4.66  4.74  4.19  4.20  3,032,157 
03/15/2024 4.45  4.89  4.43  4.66  12,811,706 
03/14/2024 4.80  4.85  4.27  4.50  4,026,376 
03/13/2024 4.86  5.11  4.80  4.88  2,562,563 
03/12/2024 5.06  5.15  4.86  4.90  3,074,600 
03/11/2024 5.26  5.42  5.01  5.08  2,735,075 
03/08/2024 5.65  5.78  5.20  5.26  2,156,712 
03/07/2024 5.70  5.73  5.36  5.57  1,558,479 
03/06/2024 5.45  5.66  5.32  5.63  1,707,340 
03/05/2024 5.44  5.63  5.29  5.40  2,313,341 
03/04/2024 5.05  5.47  4.85  5.46  2,873,603 
03/01/2024 4.94  5.07  4.88  4.94  1,412,409 
02/29/2024 5.24  5.33  4.88  4.91  1,664,363 
02/28/2024 5.11  5.38  5.02  5.12  1,574,069 
02/27/2024 4.75  5.26  4.70  5.14  2,598,267 
02/26/2024 4.50  4.69  4.47  4.63  2,636,823 
02/23/2024 4.35  4.59  4.32  4.54  1,347,446 
02/22/2024 4.44  4.52  4.23  4.36  2,961,221 
02/21/2024 4.59  4.77  4.30  4.44  2,869,061 
02/20/2024 4.70  4.85  4.41  4.65  1,794,998 
02/16/2024 4.89  4.96  4.76  4.79  1,313,378 
02/15/2024 4.97  5.08  4.83  4.96  1,603,832 
02/14/2024 4.66  4.91  4.66  4.90  2,093,876 
02/13/2024 4.64  4.87  4.53  4.61  2,744,456 
02/12/2024 4.38  4.96  4.35  4.96  2,682,725 
02/09/2024 4.39  4.49  4.27  4.38  1,857,923 
02/08/2024 4.15  4.58  4.14  4.37  2,736,253 
02/07/2024 4.12  4.19  3.91  4.15  4,076,103 
02/06/2024 4.10  4.35  4.01  4.11  2,555,921 
02/05/2024 3.96  4.24  3.85  4.14  4,058,380 
02/02/2024 3.67  4.08  3.54  4.05  2,817,679 
02/01/2024 3.55  3.75  3.47  3.71  1,522,063 
01/31/2024 3.60  3.69  3.48  3.52  2,583,000 
01/30/2024 3.47  3.71  3.42  3.60  3,195,556 
01/29/2024 3.23  3.54  3.12  3.54  1,765,693 
01/26/2024 3.23  3.33  3.20  3.24  1,537,303 
01/25/2024 3.21  3.28  3.11  3.20  1,852,658 
01/24/2024 3.25  3.26  3.14  3.16  1,596,277 
01/23/2024 3.23  3.27  3.10  3.21  1,704,407 
01/22/2024 3.11  3.24  3.05  3.16  5,653,628 
01/19/2024 3.19  3.20  3.02  3.09  2,619,777 
01/18/2024 3.17  3.22  2.98  3.20  2,632,659 
01/17/2024 3.06  3.33  3.04  3.15  2,791,805 
01/16/2024 3.16  3.16  3.01  3.13  2,200,613 
01/12/2024 3.27  3.40  3.15  3.22  3,170,831 
01/11/2024 3.10  3.43  3.07  3.21  5,489,965 
01/10/2024 3.06  3.18  2.95  3.17  3,055,724 
01/09/2024 3.07  3.15  2.99  3.05  2,695,221 
01/08/2024 2.85  3.17  2.83  3.13  4,482,521 
01/05/2024 2.80  2.93  2.61  2.92  9,749,766 
01/04/2024 3.35  3.44  3.30  3.39  1,441,514 
01/03/2024 3.57  3.57  3.29  3.33  2,675,774 
01/02/2024 3.19  3.77  3.12  3.62  5,492,913 

About Allogene Therapeutics Stock history

Allogene Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Allogene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Allogene Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Allogene Therapeutics stock prices may prove useful in developing a viable investing in Allogene Therapeutics
Last ReportedProjected for 2024
Common Stock Shares Outstanding156.9 M125.7 M
Net Loss-299.4 M-314.3 M

Allogene Therapeutics Quarterly Net Working Capital

422.04 Million

Allogene Therapeutics Stock Technical Analysis

Allogene Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Allogene Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Allogene Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Allogene Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Allogene Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Allogene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Allogene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Allogene Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Allogene Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Allogene Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Allogene Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allogene Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in Allogene Stock, please use our How to Invest in Allogene Therapeutics guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Allogene Stock analysis

When running Allogene Therapeutics' price analysis, check to measure Allogene Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allogene Therapeutics is operating at the current time. Most of Allogene Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allogene Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allogene Therapeutics' price. Additionally, you may evaluate how the addition of Allogene Therapeutics to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Allogene Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allogene Therapeutics. If investors know Allogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allogene Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.09)
Revenue Per Share
0.001
Quarterly Revenue Growth
(0.55)
Return On Assets
(0.27)
Return On Equity
(0.56)
The market value of Allogene Therapeutics is measured differently than its book value, which is the value of Allogene that is recorded on the company's balance sheet. Investors also form their own opinion of Allogene Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Allogene Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allogene Therapeutics' market value can be influenced by many factors that don't directly affect Allogene Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allogene Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allogene Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allogene Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.